| Hodgkin's Disease |
82.1% |
| Product Used For Unknown Indication |
5.3% |
| Hodgkin's Disease Stage Iii |
1.9% |
| Post Transplant Lymphoproliferative Disorder |
1.4% |
| Drug Use For Unknown Indication |
1.1% |
| Diffuse Large B-cell Lymphoma |
1.0% |
| Lymphoma |
1.0% |
| Prophylaxis |
0.9% |
| Hodgkin's Disease Recurrent |
0.8% |
| Immunodeficiency |
0.6% |
| Central Nervous System Lymphoma |
0.6% |
| Hodgkin's Disease Stage Ii |
0.5% |
| Hodgkin's Disease Stage Iv |
0.5% |
| Anaplastic Astrocytoma |
0.5% |
| Hodgkin's Lymphoma |
0.4% |
| Malignant Lymphoid Neoplasm |
0.4% |
| Chemotherapy |
0.3% |
| Gliosarcoma |
0.3% |
| Medulloblastoma |
0.3% |
| B-cell Lymphoma |
0.2% |
